REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ankay Drugs Private Limited (India)

Main Activities: Offices of All Other Miscellaneous Health Practitioners
Full name: Ankay Drugs Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Ankay Drugs Private Limited is an unlisted company, incorporated on 18/03/1996. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U85190DL1996PTC077264 and registration number is 077264. The company is a trade company, it is engaged in wholesale trading.

Legal Address
F-3/33,(Block F-3, Plot No-33) Krishna Nagar
Shahdara; Delhi; Postal Code: 110051

Contact Details: Purchase the Ankay Drugs Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ankay Drugs Private Limited report to view the information.
Registered Capital:
Purchase the Ankay Drugs Private Limited report to view the information.
Financial Auditors:
Purchase the Ankay Drugs Private Limited report to view the information.
Incorporation Date:
March 18, 1996
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Ankay Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
4.16%▲
Total operating revenue
4.19%▲
Operating profit (EBIT)
13.24%▲
Net Profit (Loss) for the Period
12.77%▲
Total assets
0.57%▲
Total equity
7.35%▲
Operating Profit Margin (ROS)
0.04%▲
Net Profit Margin
0.02%▲
Return on Equity (ROE)
0.33%▲
Debt to Equity Ratio
-29.87%▼
Quick Ratio
0.07%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo